Vaxart
Vaxart

Dividends • Vaxart

VXRT

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines based on its Vector Adjuvant Antigen Standardized Technology to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.

See below the complete and updated table with all dividends paid and declared history, etc

Excluding Date
Payment
Value ($)
Frequency
12/28/2023
1/15/2024
0,406
Quarterly
9/28/2023
10/15/2023
0,41
Quarterly
6/29/2023
7/15/2023
0,406
Quarterly
3/30/2023
4/15/2023
0,41
Quarterly
12/29/2022
1/15/2023
0,41
Quarterly
9/29/2022
10/15/2022
0,41
Quarterly
6/30/2022
7/15/2022
0,41
Quarterly
3/31/2022
4/15/2022
0,41
Quarterly